+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
544353 AMWILL

Amwill Health Care Share Price

 

 

Amwill Health Care live price: ₹41.8. It opened at ₹45 vs previous close ₹44; intraday high/low: ₹45/₹42. The 50 & 200 DMA stand at ₹36.33/₹46.42.

Amwill Health Care Performance

  • Today's Low
  • ₹42
  • Today's High
  • ₹45
  • 52 Week Low
  • ₹29
  • 52 Week High
  • ₹83
  • Open Price₹45
  • Previous Close₹44
  • Volume38,400
  • 50 DMA₹36.33
  • 100 DMA₹38.08
  • 200 DMA₹46.42

Amwill Health Care Chart

Investment Returns

  • Over 1 Month + 17.19%
  • Over 3 Month + 20.81%
  • Over 6 Month + 11.38%
  • Over 1 Year -40.71%

Smart Investing Starts Here Start SIP with Amwill Health Care for Steady Growth!

Invest Now

Amwill Health Care Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 7.3
  • PEG Ratio
  • -
  • Market Cap Cr
  • 84
  • P/B Ratio
  • 1
  • Average True Range
  • 1.88
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.31
  • RSI
  • 63.98
  • MFI
  • 76.97

Latest Stock News Updates

Amwill Healthcare share price lists with 20% discount at 89 apiece on BSE SME

Amwill Healthcare's share price made a weak stock market debut on Wednesday, February 12, listing at a steep 20% discount at 88.85 apiece.

Amwill Health Care Financials

Amwill Health Care Technicals

EMA & SMA

Current Price
₹41.80
-2.2 (-5%)
pointer
  • Bearish Moving Average 3
  • Bullish Moving Average 13
  • 20 Day
  • ₹37.90
  • 50 Day
  • ₹36.30
  • 100 Day
  • ₹38.10
  • 200 Day
  • ₹46.40

Resistance and Support

42.88 Pivot Speed
  • R3 47.16
  • R2 46.08
  • R1 43.96
  • S1 40.76
  • S2 39.68
  • S3 37.56

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

AMWILL HEALTHCARE is one of India's fastest-growing dermatology companies, specializing in dermatology, trichology, and cosmetology. It offers high-quality skincare solutions, manufacturing in GMP & WHO-certified units, covering major skin disorders with DCGI-approved medicines for dermatologists and cosmetologists across India.

Amwill Healthcare Ltd has an operating revenue of Rs. 109.23 Cr. on a trailing 12-month basis. An annual revenue growth of 17% is outstanding, Pre-tax margin of 34% is great, ROE of 14% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 200DMA and around 26% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 94 which is a GREAT score indicating consistency in earnings, a RS Rating of 64 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 74 indicates it belongs to a poor industry group of Medical-Whlsle Drg/Suppl and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Amwill Health Care Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-30 Audited Results & Final Dividend
2025-11-04 Half Yearly Results (Revised)
2025-05-29 Audited Results

Amwill Health Care Shareholding Pattern

70.65%
0%
26.37%
2.98%

Amwill Health Care FAQs

Amwill Health Care share price is ₹41 As on 14 June, 2026 | 15:45

The Market Cap of Amwill Health Care is ₹83.6 Cr As on 14 June, 2026 | 15:45

The P/E ratio of Amwill Health Care is 7.3 As on 14 June, 2026 | 15:45

The PB ratio of Amwill Health Care is 1 As on 14 June, 2026 | 15:45

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23